Alleviation of apoptosis and complement
|
|
|
|
Bach et al. |
Hamster to rat heart xenografts |
Heart xenografts could acquire accommodation by upregulation of a number of antiapoptotic and anti-inflammatory genes including A20, Bcl-2, Bcl-xl, and hemeoxygenase-1 in endothelial cells. |
[54] |
Salama et al. |
Human renal transplantation with HLA antibodies |
Immunohistochemistry of the graft biopsies demonstrated increased expression of antiapoptotic protein Bcl-xl in glomerular and peritubular capillary endothelial cells. In vitro experiments confirmed that endothelial cells with upregulated Bcl-xl were rendered resistant to complement-dependent cytotoxicity. |
[55] |
Chen et al. |
Renal transplantation in skin-presensitized nonhuman primates |
Antiapoptotic proteins and complement regulatory proteins such as Bcl-2, CD59, CD46, and clusterin might contribute to allografts' accommodation. |
[56] |
Iwasaki et al. |
In vitro study of the effects of anti-HLA and anti-A/B antibody binding on complement-mediated cytotoxicity and signal transduction |
Accommodation for anti-A/B antibodies relied on unregulated complement regulatory proteins CD55 and CD59 induced by suppressed ERK1/2 pathway, whereas in the background of anti-HLA antibodies activated PI3K/AKT pathway of endothelial cells led to expression of cytoprotective molecules such as hemeoxygenase-1 and ferritin H. |
[57] |
|
Blood group alteration or chimerism
|
|
|
|
Tanabe et al. |
ABOi renal transplant recipients |
Time-dependent downregulation of donor's blood-type antigen on the graft endothelium was observed, which might contribute to the long-term accommodation after ABOi kidney transplantation. |
[58] |
Tanabe et al. |
ABOi renal transplant recipients |
Detectable antigenic chimerism on the graft endothelium was confirmed. |
[59] |